Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your healthcare professional for further information.
DIFICLIR™ (fidaxomicin) is a macrocyclic anti-bacterial agent, formulated as film-coated tablets and granules for oral suspension. The tablets are indicated for the treatment of Clostridioides difficile infections (CDI) in adult and paediatric patients with a body weight of at least 12.5 kg. The granules are indicated in CDI in adults and paediatric patients from birth to < 18 years of age.
Important information on Dificlir and its use can be found in the Summary of Product Characteristics, Dificlir tablets and Dificlir granules.